Pfam Domains GO Terms
| PI3 PI4 kinase |
| 1-phosphatidylinositol 4-kinase activity |
| rough endoplasmic reticulum membrane |
| 14-3-3 protein binding |
| phosphatidylinositol phosphorylation |
| lipid phosphorylation |
| phosphatidylinositol-mediated signaling |
| inositol lipid-mediated signaling |
| phosphatidylinositol biosynthetic process |
| mitochondrial outer membrane |
| phosphatidylinositol metabolic process |
| lipid modification |
| glycerophospholipid biosynthetic process |
| glycerolipid biosynthetic process |
| receptor-mediated endocytosis |
| phospholipid biosynthetic process |
| endosome |
| glycerophospholipid metabolic process |
| phospholipid metabolic process |
| glycerolipid metabolic process |
| organophosphate biosynthetic process |
| endocytosis |
| lipid biosynthetic process |
| Golgi membrane |
| import into cell |
| perinuclear region of cytoplasm |
| organophosphate metabolic process |
| cellular lipid metabolic process |
| lipid metabolic process |
| phosphorylation |
| ATP binding |
| intracellular signal transduction |
| vesicle-mediated transport |
| membrane |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 2/28 |
| bone | 1/26 |
| breast | 0/33 |
| central nervous system | 2/56 |
| cervix | 0/4 |
| colorectal | 1/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 2/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution